News | News By Subject | News by Disease News By Date | Search News

Rotavirus infection News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Panel Members Back Use Of Merck & Co., Inc. (MRK), GlaxoSmithKline (GSK) Rotavirus Vaccines     5/10/2010
Pig Virus DNA Found In Merck & Co., Inc. (MRK) Rotavirus Vaccine; FDA Panel To Weigh Merck, GlaxoSmithKline (GSK) Vaccines Friday     5/7/2010
FDA Asks Doctors to Temporarily Halt Use of GlaxoSmithKline (GSK)'s Rotarix Vaccine     3/23/2010
U.S. Panel (JOBS) Recommends GlaxoSmithKline (GSK) (JOBS) and Merck & Co., Inc. (MRK)'s (JOBS) Rotavirus Vaccines     6/26/2008
FDA Approves GlaxoSmithKline (GSK)'s ROTARIX(R) Rotavirus Vaccine     4/4/2008
GlaxoSmithKline (GSK) Awaits FDA Decision on Vaccine     2/20/2008
GlaxoSmithKline (GSK) Rotavirus Vaccine Has Some Safety Issues Says FDA     2/15/2008
GlaxoSmithKline (GSK)'s (Jobs) Application for Rotarix(R) is Accepted for Review by the FDA     8/14/2007
Bowel Problem Seen In Infants Given Merck & Co., Inc. (MRK) (Jobs) Vaccine     2/14/2007
Avant Immunotherapeutics (AVAN) Announces European Regulatory Authorities Approve Rotarix(R) Rotavirus Vaccine     2/27/2006
FDA Approves Merck & Co., Inc. (MRK)'s ROTATEQ(R), The Only Vaccine In The U.S. To Prevent Rotavirus Gastroenteritis     2/6/2006
GlaxoSmithKline Biologicals (GSK) And Merck & Co., Inc. (MRK): Two Investigational Rotavirus Vaccines Safe and Effective     1/5/2006
The Wistar Institute Sells Partial Royalty Interest In Merck & Co., Inc. (MRK)'s ROTATEQ(R) To The Paul Royalty Fund     12/15/2005

News from Around the Web

Press Releases
Meridian Life Science Awarded SBIR by Centers for Disease Control and Prevention (CDC) to Develop Rotavirus Vaccine     10/31/2013
GlaxoSmithKline (GSK), Merck & Co., Inc. (MRK), Sanofi-Aventis (France) (SASY.PA) Rotavirus Vaccines Save Poorest Children     8/6/2010
FDA Says Healthcare Providers Can Resume Use of GlaxoSmithKline (GSK)'s Rotarix (Rotavirus Vaccine, Live, Oral)     5/17/2010
Merck & Co., Inc. (MRK) Release: Rotateq(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New U.S. Observational Study     10/27/2008
Merck & Co., Inc. (MRK)'s ROTATEQ(R) Reduced Hospitalizations and Emergency Department Visits Due to G9P1A(8) Rotavirus by 100 Percent as Shown by Post-hoc Analysis of Data     12/3/2007
American Type Culture Collection Vero Cells Supplied For Rotavirus Vaccine Commercialization     2/13/2007
Rotavirus Vaccine Manufacturing Agreement Between BIOVIRx And IDT     3/27/2006
Avant Immunotherapeutics (AVAN) Receives $4 Million Milestone Payment From GlaxoSmithKline (GSK), Triggered By Approval Of Rotarix(R) By European Regulatory Authorities     3/8/2006
Merck & Co., Inc. (MRK) Submits Biologics License Application To FDA For ROTATEQ--R--, An Investigational Vaccine For Rotavirus     4/11/2005
Avant Immunotherapeutics's (AVAN) Partner, GlaxoSmithKline, (GSK) Begins Global Launch Of Rotarix In Mexico     1/10/2005